// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The Combination of Malnutrition Inflammation and Limitations in Functional Status Is Associated with a Very High Risk of Mortality in Hemodialysis Patients: Results from the DOPPS

Lopes Marcelo - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

CKD Predicts Stroke Severity, Disability, and Early Recurrence in a Population-Based Cohort Study

Kelly Dearbhla - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Cardiovascular Determinants of Physical Function in Patients with ESKD on Hemodialysis

Adenwalla ShernaF - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant Patients: A Randomised Controlled Trial

Ross LouiseE - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Albuminuria

N/A

Aetiological Subtypes of Transient Ischemic Attack and Ischaemic Stroke in CKD: A Population-Based Study

Kelly Dearbhla - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Using Skin Biopsies to Measure Target Occupancy of a Renal Antifibrotic Monoclonal Antibody (mAb) in a Phase 1 Clinical Study

Bowcutt Rowann - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Determining the Optimal Dose of Cholecalciferol Supplementation for Children with CKD (C3 Trial): An Open-Label Multicentre Randomized Controlled Trial

Iyengar ArpanaA - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

cholecalciferol

Hemodiafiltration Maintains a Sustained Improvement in BP Compared with Conventional Hemodialysis in Children: The HDF, Heart and Height (3H) Study

De Zan Francesca - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Predicting Allograft Survival in Young Pediatric Kidney Transplant Recipients

Manca Barayre Florian - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Point-of-Care Creatinine Self-Testing in Renal Transplant Patients: An Assessment of Accuracy, Precision, and Patient Experience

Fernandes da Costa Fabiana - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Demographic Variability of Kidney Function in Live Donors: A Single-Centre Analysis

Thomson Tina - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Two Deaths of Acute Transplant Patients from Strongyloides Hyperinfection Syndrome (SHS): Can We Prevent Harm with Screening and Prophylaxis at the Time of Transplantation?

Hawkins-van der Cingel Gerlineke�Mc - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ivermectin

Adjusted Donor Age Score: Validity and Influence on Deceased Donor Offer Decisions

Mahler Christoph�Friedrich - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Retrospective Analysis of Post-Transplant Erythrocytosis: The Experience of a Tertiary Kidney Transplant Unit

Deoraj StuartR - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal disease

N/A

Impact of Renal Transplantation on Functional Status in Tacrolimus Era

Mohamed MahmoudMagdy - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Transplant rejection

Tacrolimus

Fludrocortisone Corrects Tacrolimus-Associated Hyperkalemia in Renal Transplant Patients

Gama Rouvick - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hyperkalemia

Fludrocortisone

Pregnancy Following Kidney Transplantation: Experience of a Tertiary Renal Obstetric Service Between 1996 and 2020

Gleeson Sarah - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identification of Renal Disease in Women with Hypertensive Pregnancies

Martin Hayley - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Renal disease

N/A

Effect of Ertugliflozin on Initial eGFR Decline and Chronic Slope: Analyses from the VERTIS CV Trial

Cherney David - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

Ertugliflozin

Canagliflozin Across the Spectrum of Kidney Function and Albuminuria: Integrated Data from CANVAS and CREDENCE

Neuen BrendonLange - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

Canagliflozin

Copyright © 2026. QuantiNova All rights reserved